Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin

S E Tsirka1, T H Bugge, J L Degen

  • 1Department of Pharmacology, University Medical Center at Stony Brook, Stony Brook, NY 11794-8651, USA.

Insights

Mice lacking plasminogen are resistant to neurodegeneration. Surprisingly, this resistance persists even without fibrinogen, indicating plasmin acts on non-fibrin targets in the central nervous system.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Physiology

Background:

  • Plasminogen deficiency in mice reverses pathologies linked to fibrinogen.
  • Plasminogen's primary role was thought to be fibrin clearance.
  • Plasminogen-deficient mice show resistance to excitotoxin-induced neurodegeneration.

Purpose of the Study:

  • To investigate if plasminogen's neuroprotective effect depends on fibrinogen.
  • To determine if plasmin acts on non-fibrin substrates in neurodegeneration.

Main Methods:

  • Genetic manipulation of mice to create single and double deficiencies for plasminogen and fibrinogen.
  • Assessment of resistance to excitotoxin-induced neurodegeneration in these mouse models.

Main Results:

  • Mice lacking both plasminogen and fibrinogen were resistant to neurodegeneration.
  • This resistance was comparable to that observed in plasminogen-deficient mice.
  • Plasminogen's role in neurodegeneration is not solely dependent on fibrinogen clearance.

Conclusions:

  • Plasmin targets substrates other than fibrin during experimental neuronal degeneration.
  • Plasmin may play a significant role in other central nervous system pathologies.
  • Further research is needed to identify non-fibrin targets of plasmin in the brain.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...